UBS Group’s Sanaby Health Acquisition Corp. I Unit SANBU Stock Holding History

UBS Group’s Portfolio SANBU Stock Details SANBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-239	Closed	-$2K	–	11947
2022 Q3	$2K	Hold	239	–	–	﹤0.01%	9889
2022 Q2	$2K	Buy	239 +200	+513%	+$2.02K	﹤0.01%	9760
2022 Q1	$0	Sell	39 -717	-95%	-$7.26K	﹤0.01%	11426
2021 Q4	$8K	Buy	+756	New	+$7.66K	﹤0.01%	9113

UBS Group's SANBU Position: Q4 2022 in Review

UBS Group sold out of Sanaby Health Acquisition Corp. I Unit (SANBU) in Q4 2022, closing a stake of 239 shares — an estimated $2K sold.

UBS Group first reported a position in SANBU in Q4 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 0 funds tracked by Wall St. Rank hold SANBU as of Q4 2022.

UBS Group reported no remaining Sanaby Health Acquisition Corp. I Unit position as of Q4 2022 after selling out during the quarter.
UBS Group sold 239 Sanaby Health Acquisition Corp. I Unit shares in Q4 2022, an estimated $2K.
UBS Group first reported a position in Sanaby Health Acquisition Corp. I Unit in Q4 2021 and held it in 4 quarters.
UBS Group's Sanaby Health Acquisition Corp. I Unit position peaked at $8K in Q4 2021.
0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Unit as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.